|
Statements of Operations (USD $)
|
12 Months Ended | 27 Months Ended | |
|---|---|---|---|
|
Jan. 31, 2013
|
Jan. 31, 2012
|
Jan. 31, 2013
|
|
| Revenue | |||
| Revenue | $ 11 | $ 0 | $ 11 |
| Operating Costs | |||
| Accounting | 12,585 | 0 | 12,585 |
| Amortization | 2,007 | 0 | 2,007 |
| Consulting services | 10,741 | 0 | 10,741 |
| General and Administrative | 21,231 | 12,687 | 24,011 |
| Legal | 6,450 | 2,500 | 19,137 |
| Research & development | 9,731 | 0 | 9,731 |
| Total Operating Costs | 62,745 | 15,187 | 78,212 |
| Income(Loss) from operations | (62,734) | (15,187) | (78,201) |
| Other Income (Expense) | |||
| Interest expense | (984) | 0 | (984) |
| Interest income | 10 | 0 | 10 |
| Total Other Income | (974) | 0 | (974) |
| Net Income(Loss) | $ (63,708) | $ (15,187) | $ (79,175) |
| Basic earnings per share (in dollars per share) | $ (0.01) | $ (0.01) | |
| Weighted average number of common shares outstanding basic and diluted (in shares) | 8,651,083 | 1,980,412 | |
| X | ||||||||||
|
- Definition
Represents the costs incurred for consulting services. No definition available.
|
| X | ||||||||||
|
- Definition
The amount of interest income recognized during the period. No definition available.
|
| X | ||||||||||
|
- Definition
The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of the cost of borrowed funds accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The net result for the period of deducting operating expenses from operating revenues. No definition available.
|
| X | ||||||||||
|
- Definition
A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Aggregate revenue during the period from services rendered in the normal course of business, after deducting allowances and discounts. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS). No definition available.
|